According to numerous investigations, STAT3 activity is also a survival signal that guards against lipotoxicity, whereas blocking hepatic STAT3 activation with other drugs reduces NAFLD-induced liver fibrosis [82]. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatotic liver disease.